Medication info
Amloban Tablets 5/80 mg

Amloban Tablets 5/80 mg

Prescription medicationTabletOral
Ingredient · strength
Amlodipine Besylate›6.94mg / 1 tabletValsartan›80mg / 1 tablet
Manufacturer / importer
Samchundang Pharmaceutical Co., Ltd.
Appearance
Dark yellow round film-coated tablet
Packaging
30 tablets (10 tablets/Alu-Alu) x 3
Approval status
Active

MFDS item code 201308569 · Approved 2013.07.31 · Insurance code 651203930

Summary

Main use
Treatment of essential hypertension not adequately controlled with amlodipine or valsartan monotherapy
Who takes it
Adults · Children
Adult dose
The recommended dose is 1 tablet once daily, taken with water, with or without food. If possible, it is recommended that the tablet be taken at the same time each day (e.g., in the morning). It is recommended that the doses of the individual components (amlodipine or valsartan) be adjusted before this medicine is administered. However, if blood pressure is not controlled with monotherapy with the individual components, switching directly to this medicine may be considered as follows. ㆍ5/80 mg: For patients whose blood pressure is not adequately controlled with monotherapy with amlodipine 5 mg or valsartan 80 mg. ㆍ5/160 mg: For patients whose blood pressure is not adequately controlled with monotherapy with amlodipine 5 mg or valsartan 160 mg. ㆍ10/160 mg: For patients whose blood pressure is not adequately controlled with monotherapy with amlodipine 10 mg or valsartan 160 mg, or with 5/160 mg. Patients taking valsartan and amlodipine concomitantly may switch to this medicine (a combination product containing the same amounts of each active ingredient) for convenience. Patients with renal impairment: No dose adjustment is necessary in patients with mild or moderate renal impairment (creatinine clearance 10mL/min or greater). This medicine should not be administered to patients with severe renal impairment (creatinine clearance less than 10mL/min) or patients on dialysis. Monitoring of potassium levels and creatinine is recommended in patients with moderate renal impairment. Patients with hepatic impairment: In patients with mild or moderate hepatic impairment, the daily dose of valsartan should not exceed 80mg. This medicine should not be administered to patients with severe hepatic impairment, biliary cirrhosis, or biliary obstruction or cholestasis. Patients aged 65 years or older: Use caution when increasing the dose.
Child dose
The safety and efficacy of this medicine have not been established in pediatric patients under 18 years of age; therefore, its use is not recommended.

Ingredients

Manufacturer
Samchundang Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of essential hypertension not adequately controlled with amlodipine or valsartan monotherapy

  • Essential hypertension
View approved original text

This medication is used to effectively treat essential hypertension when blood pressure control with monotherapy of amlodipine or valsartan is insufficient.

How to take

Adult dose

The recommended dose is 1 tablet once daily, taken with water, with or without food. If possible, it is recommended that the tablet be taken at the same time each day (e.g., in the morning). It is recommended that the doses of the individual components (amlodipine or valsartan) be adjusted before this medicine is administered. However, if blood pressure is not controlled with monotherapy with the individual components, switching directly to this medicine may be considered as follows. ㆍ5/80 mg: For patients whose blood pressure is not adequately controlled with monotherapy with amlodipine 5 mg or valsartan 80 mg. ㆍ5/160 mg: For patients whose blood pressure is not adequately controlled with monotherapy with amlodipine 5 mg or valsartan 160 mg. ㆍ10/160 mg: For patients whose blood pressure is not adequately controlled with monotherapy with amlodipine 10 mg or valsartan 160 mg, or with 5/160 mg. Patients taking valsartan and amlodipine concomitantly may switch to this medicine (a combination product containing the same amounts of each active ingredient) for convenience. Patients with renal impairment: No dose adjustment is necessary in patients with mild or moderate renal impairment (creatinine clearance 10mL/min or greater). This medicine should not be administered to patients with severe renal impairment (creatinine clearance less than 10mL/min) or patients on dialysis. Monitoring of potassium levels and creatinine is recommended in patients with moderate renal impairment. Patients with hepatic impairment: In patients with mild or moderate hepatic impairment, the daily dose of valsartan should not exceed 80mg. This medicine should not be administered to patients with severe hepatic impairment, biliary cirrhosis, or biliary obstruction or cholestasis. Patients aged 65 years or older: Use caution when increasing the dose.

Child dose

The safety and efficacy of this medicine have not been established in pediatric patients under 18 years of age; therefore, its use is not recommended.

Precautions

This medication can cause serious harm to the fetus and newborn if taken during the second or third trimester of pregnancy, so it should be discontinued immediately upon confirmation of pregnancy. Patients with allergies to the main ingredients of this medication or similar drugs, pregnant or breastfeeding women, patients with severe renal or hepatic impairment, and patients with a history of certain heart diseases or angioedema should not take this medication. Patients with low sodium or fluid levels are at risk of hypotension, so their condition should be carefully checked before use, and blood pressure and condition should be closely monitored during treatment. Patients with high potassium levels or those taking potassium supplements should have their serum potassium levels frequently checked and use caution. Patients with renal issues or those who have received kidney transplants, patients with a history of angioedema, patients recovering from heart failure or a heart attack, and patients with acute myocardial infarction should take this medication with special care. Dizziness, drowsiness, headache, swelling, hypotension, skin rash, and gastrointestinal disturbances may occur during treatment, and if symptoms are severe, consultation with a physician is necessary. Dizziness or fatigue may occur during driving or operating machinery, so caution is needed. This medication may interact with other antihypertensive drugs, potassium-sparing diuretics, certain antibiotics, and anti-inflammatory drugs, so it is essential to disclose any co-administered medications. Women who are pregnant or planning to become pregnant should not use this medication, and it is also advisable for breastfeeding women to avoid this medication. Safety and efficacy in children under 18 years of age have not been sufficiently established, so its use is not recommended. In case of overdose, hypotension, dizziness, or in severe cases, shock may occur, so the dosage should not be exceeded, and if unusual symptoms arise, medical attention should be sought immediately.

Side effects

nasopharyngitis, influenza, hypersensitivity, visual impairment, anxiety, headache, dizziness, drowsiness, positional dizziness, paresthesia, vertigo, tinnitus, tachycardia, palpitations, syncope, orthostatic hypotension, hypotension, cough, pharyngeal and laryngeal pain, diarrhea, nausea, abdominal pain, constipation, dry mouth, rash, erythema, hyperhidrosis, itching, joint swelling, low back pain, arthritis, muscle spasms, lethargy, polyuria, nocturia, erectile dysfunction, edema, localized edema, facial edema, peripheral edema, fatigue, flushing, weakness, facial flushing, decreased hemoglobin, decreased hematocrit, neutropenia, thrombocytopenia, hypersensitivity including serum sickness, increased serum potassium, vasculitis, elevated liver function tests, angioedema, myalgia, renal failure, kidney damage, elevated serum creatinine, insomnia, decreased libido, pharyngitis, rhinitis, sinusitis, upper respiratory infection, viral infection, double vision, thrombocytopenia, leukopenia, allergic reaction, hyperglycemia, insomnia, mood changes, tremors, sensory disturbance, taste alteration, peripheral neuropathy, hypertonia, arrhythmia, bradycardia, atrial fibrillation, ventricular tachycardia, myocardial infarction, vasculitis, dyspnea, rhinitis, vomiting, dyspepsia, pancreatitis, gastritis, gingival hyperplasia, hepatitis, jaundice, alopecia, purpura, skin depigmentation, photosensitivity reaction, angioedema, urticaria, erythema multiforme, Stevens-Johnson syndrome, myalgia, urination disorders, nocturnal enuresis, gynecomastia, pain, malaise, chest pain, weight loss, weight gain, increased liver enzymes, chest discomfort, abdominal discomfort, gastroesophageal reflux disease, neck pain, hypercholesterolemia, hypoglycemia, neuroexcitation, Stevens-Johnson syndrome, chest pain, weight gain, arthralgia, skeletal pain, rhabdomyolysis, gingival hyperplasia, gastritis, sensory disturbance

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly closed container to protect it from air and moisture, and it is safe to keep it at room temperature between 1 and 30 degrees Celsius. Storing it this way can maintain the medication's effectiveness for a longer time.

Appearance and packaging

Appearance

Dark yellow round film-coated tablet

Package unit

30 tablets (10 tablets/Alu-Alu) x 3

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.